e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.18 -0.14 (-0.40%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? ↗

December 12, 2023

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.

Via The Motley Fool

Why Viking Therapeutics Was Crushing It This Week ↗

December 08, 2023

Nowadays, it's good to be a developer of next-generation weight loss drugs.

Via The Motley Fool

What's Going On With Viking Therapeutics Shares Tuesday? ↗

November 14, 2023

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b study

Via Benzinga

1 Under-the-Radar Stock That Could Triple By 2030 ↗

November 04, 2023

This small-cap biotech stock is going to compete against some giants.

Via The Motley Fool

Earnings Scheduled For October 25, 2023 ↗

October 25, 2023

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.

Via Benzinga

Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders

October 19, 2023

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END

Via FinancialNewsMedia

2 Magnificient Growth Stocks I'm Buying in August ↗

August 02, 2023

These biotech stocks could markedly outperform the broader market.

Via The Motley Fool

Why Are Stocks Down Today? ↗

October 18, 2023

Stocks are down again on Wednesday as investors continue to feel the effects of several major catalysts hitting the market.

Via InvestorPlace

Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts ↗

October 18, 2023

Pfizer layoffs are a hot topic among PFE stock traders on Wednesday as they pour over the details of the job cuts amid a Covid slump.

Via InvestorPlace

Topics Workforce

Why Is Viking Therapeutics (VKTX) Stock Moving Today? ↗

October 18, 2023

Viking Therapeutics stock is on the move Wednesday as investors react to results from the company's latest clinical trial!

Via InvestorPlace

Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 18, 2023

Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court...

Via Benzinga

Topics Bankruptcy

9 Analysts Have This to Say About Viking Therapeutics ↗

July 27, 2023

Via Benzinga

Earnings Preview: Viking Therapeutics ↗

July 25, 2023

Via Benzinga

Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business' ↗

October 11, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair.

Via Benzinga

Consolidation In Viking Therapeutics Provides An Opportunity ↗

October 01, 2023

Viking Therapeutics Inc. (VKTX) is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases.

Via Talk Markets

Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday ↗

September 18, 2023

U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

3 Biotechs Compete for the Same $108-Billion-Dollar Market. Are They a Buy? ↗

August 23, 2023

NASH treatments are projected to be one of the most sought-after indications in the coming years.

Via The Motley Fool

Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It ↗

August 23, 2023

NASH is a surprisingly common ailment, and the first treatments are on the way.

Via The Motley Fool

The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023 ↗

August 16, 2023

All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 08, 2023

Via Benzinga

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today ↗

August 08, 2023

Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study.

Via The Motley Fool

Lilly Shares Up On Versanis Deal Amid Weight-Loss Drug Gold Rush

July 24, 2023

A bid to acquire Versanis boosts Eli Lilly & Co. by 2.80% in the past week, as the competition to develop the most effective weight-loss drug intensifies.

Via MarketBeat

3 Small-Cap Stocks That Could Be Big-Time Winners ↗

July 22, 2023

These stocks come with significant risks. But they could generate huge returns over time.

Via The Motley Fool

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly? ↗

July 13, 2023

An overweight world is hungry for new treatments. For now, two companies own the market.

Via Investor's Business Daily

3 Top Biotech Stocks Defying the Bear Market ↗

July 13, 2023

Each has the potential to dramatically outperform the market.

Via The Motley Fool

2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher ↗

July 12, 2023

Are analysts right to be so bullish about these stocks?

Via The Motley Fool

The 3 Best Momentum Stocks to Buy in July ↗

July 07, 2023

For those who identify the right shares at the right time, the rewards of momentum stocks far outstrip those of their competitors.

Via InvestorPlace

The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023 ↗

June 29, 2023

If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.

Via InvestorPlace

Better Buy: Nano-X Imaging vs. Viking Therapeutics ↗

June 29, 2023

Which healthcare stock is the better option for growth investors?

Via The Motley Fool

Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says ↗

June 28, 2023

Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) shares lost more than 25% of their value due to investor pressure it faced after Eli Lilly And Co (NYSE: LLY) announced data from retatrutide that was...

Via Benzinga

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy